Drug Sponsors

Oxygen Biotherapeutics relocating R&D function to North Carolina

Wednesday, August 29, 2012 10:04 AM

Oxygen Biotherapeutics, a Morrisville, N.C.-based developer of medical and cosmetic products that efficiently deliver oxygen to tissues in the body, is searching for laboratory space in the Research Triangle Park region of North Carolina.

More... »

Pascal Soriot named AstraZeneca CEO

Tuesday, August 28, 2012 03:06 PM

AstraZeneca has announced Pascal Soriot’s appointment as the company’s chief executive officer. He will assume the new role and join the AstraZeneca board as an executive director as of Oct. 1.

More... »

Alnylam and Monsanto form strategic alliance

Tuesday, August 28, 2012 02:51 PM

St. Louis-based Monsanto and Alnylam Pharmaceuticals of Cambridge, Mass., have formed a strategic alliance to advance biological technologies in the field of agriculture. The new alliance brings Alnylam's broad RNAi-based intellectual property (IP) and proprietary technologies to Monsanto's new BioDirect technology, which aims to deliver innovative biological solutions for farmers.

More... »

Pristine Solutions acquires Eaton Scientific Systems

Monday, August 27, 2012 12:08 PM

Pristine Solutions has completed the acquisition of Eaton Scientific Systems, a biomedical product development company focused on women's health solutions.

More... »

Agennix announces corporate restructuring

Friday, August 24, 2012 02:48 PM

Agennix has announced a restructuring that involves staff reductions of approximately 55% of the company's workforce. The restructuring is being implemented to conserve cash as management determines the company’s next strategic steps.

More... »

Pfizer, Mylan ink exclusive long-term collaboration for generics in Japan

Thursday, August 23, 2012 02:02 PM

Global research-based pharmaceutical company Pfizer and Canonsburg, Penn.-based pharmaceutical company Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaboration to develop, manufacture, distribute and market generic drugs in Japan.

More... »

Transgenomic awarded NIH STTR grant for pancreatic cancer research

Thursday, August 23, 2012 11:15 AM

Transgenomic,an Omaha, Neb.-based global biotechnology company focused on personalized medicine, has been awarded a $100,000 Small Business Technology Transfer Program (STTR) phase I grant by the National Institutes of Health’s National Center For Advancing Translational Sciences.

More... »

West Pharma breaks ground on new manufacturing facility in India

Thursday, August 23, 2012 10:46 AM

West Pharmaceutical India Packaging, an indirect subsidiary of West Pharmaceutical Services, began construction of its new compression molding facility located in Sri City, India.

More... »

Proteonomix licenses exclusive worldwide rights to novel anti-tumor technology

Thursday, August 23, 2012 10:19 AM

Proteonomix, a Hawthorne, N.J.-based biotechnology company focused therapeutics based upon the use of human cells and their derivatives, has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.

More... »

EMD Millipore to acquire Biochrom

Thursday, August 23, 2012 09:54 AM

EMD Millipore, the life science division of Merck of Darmstadt, Germany, has decided to acquire Biochrom, a cell culture media specialist of Berlin, Germany. The closing price was not disclosed.

More... »